Lower Atrial Fibrillation Risk With Sodium-Glucose Cotransporter 2 Inhibitors Than With Dipeptidyl Peptidase-4 Inhibitors in Individuals With Type 2 Diabetes: A Nationwide Cohort Study
-
- Korean Circulation Journal
- /
- 제54권5호
- /
- pp.256-267
- /
- 2024